EPSILEN BIO
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases. Epsilen Bio's mission is to develop therapies for patients affected by underserved medical conditions, through stable genomic epigenetic silencing of genes involved in pathological processes. The company was founded in December 2019 and based in Milan, Italy.
EPSILEN BIO
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2019-12-01
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.epsilenbio.com
Total Employee:
1+
Status:
Active
Contact:
39 02 83991325
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
CiMaas
CiMaas develops immunotherapy for cancer by optimally engaging the immune system.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
PB Bioscience
PB Bioscience works with leading international and national industries operating in the health and wellness.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-18 | Chroma Medicine | Chroma Medicine acquired by Epsilen Bio | N/A |
Investors List
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Epsilen Bio
Official Site Inspections
http://www.epsilenbio.com
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
